MitoRx Therapeutics grabs seed

MitoRx Therapeutics, a developer of novel therapeutics that reverse mitochondrial dysfunction, has secured an undisclosed amount of seed funding.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this